Biotech, Trinity

Trinity Biotech climbs after data for glucose monitoring device
Trinity Biotech (TRIB) stock gains on encouraging data from a pre-pivotal clinical trial for its next-gen continuous glucose monitoring ((CGM)) system. Read more here.
Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology
Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB),
Trinity Biotech Shares Rise After Update on Next-Gen Blood-Sugar Monitoring Device
Shares of Trinity Biotech climbed after the company released what it called compelling results from a study of its next-generation continuous glucose monitoring system, a device used for diabetes management that measures blood sugar levels in real time.
Trinity Biotech announces results from pre-pivotal trial for CGM system
Trinity Biotech (TRIB) announced results from its latest pre-pivotal clinical trial for its next-generation continuous glucose monitoring
Trinity Biotech announces breakthrough in CGM technology
DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), an Ireland-based biotech firm with a market capitalization of $13.24 million, revealed promising results from a recent pre-pivotal clinical trial for its innovative continuous glucose monitoring (CGM) system.
What's Going On With Trinity Biotech Shares Tuesday?
Trinity stock is trading higher on Tuesday after the company announced results from its pre-pivotal clinical trial for its ...
Trinity Biotech faces US aid policy impact, PPP loan scrutiny
Trinity Biotech plc (NASDAQ:TRIB), an Ireland-based diagnostic company with a market capitalization of $23.7 million and current trading price of $1.32, is evaluating the potential effects of a recent ...
bovnews2d
Trinity Biotech’s (TRIB) Breakthrough Technology Shakes Up the Diabetes Market
But what exactly is driving this sudden attention towards Trinity Biotech, and how does it compare to broader market trends? Let’s explore. Trinity Biotech is a commercial-stage biotechnology company ...
ETF Daily News4d
Trinity Biotech (TRIB) Expected to Announce Quarterly Earnings on Wednesday
10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Trinity Biotech plc acquires, together with its subsidiaries, develops ...
Nasdaq1mon
Trinity Biotech plc Secures Additional Liquidity Through Amended Agreements with Perceptive Advisors to Support Comprehensive Transformation Plan
Trinity Biotech plc announced revised agreements with its primary lender, Perceptive Advisors, to improve its financial position as the company implements its Comprehensive Transformation Plan and ...
Yahoo Finance20d
Trinity Biotech plc (TRIB)
DUBLIN, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...
Benzinga.com11mon
Trinity Biotech (NASDAQ:TRIB) Stock Quotes, Forecast and News Summary
Trinity stock is trading higher on Tuesday after the company announced results from its pre-pivotal clinical trial for its continuous glucose monitoring system. Trinity Biotech plc (NASDAQ: TRIB ...
Stocktwits on MSN1d
TRIB, SLXN, STSS: Why Retail Chatter On 3 Nano-Cap Healthcare Stocks Exploded Over 6000%
Three nano-cap healthcare stocks drew massive attention from retail investors on Stocktwits Tuesday, though not all for ...